Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advanced Cell Technology to Present at the Harris Nesbitt Focus on Healthcare Conference on December 8th.


WORCESTER, Mass. -- Advanced Cell Technology, Inc. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB: ACTC ACTC Apple Certified Technical Coordinator
ACTC Almaden Cycle Touring Club
ACTC Associated Colleges of the Twin Cities
ACTC All Ceylon Tamil Congress (Sri Lanka)
ACTC Association Canadienne de Télévision par Câble
) will participate in the Harris Nesbitt Focus on Healthcare Conference scheduled for Thursday, December 8, 2005, at the Millennium Broadway Hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
. James G. Stewart, Chief Financial Officer, is scheduled to make a presentation and then participate in a panel discussion, "Stem Cell-Based Medicine: The State of the Art" beginning at 1:30 p.m. EST. The presentation can be accessed on the investor relations Investor relations

The process by which the corporation communicates with its investors.
 page of the company's website, http://www.advancedcell.com.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 technology in the emerging field of regenerative re·gen·er·a·tive  
adj.
1. Of, relating to, or marked by regeneration.

2. Tending to regenerate.



re·gen
 medicine. The company is currently headquartered in Worcester, Massachusetts. For more information about the company, visit http://www.advancedcell.com

Forward-Looking Statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2005.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 7, 2005
Words:353
Previous Article:OAG(R) Publishes the Most Comprehensive Book Ever Written on Mastering Travel Loyalty Programs.
Next Article:Jabil Acquires Texas Operations of Incline Global Technology Services, Inc.; Expands Capabilities in LCD and Plasma Display Services Market.
Topics:



Related Articles
SEQUENOM Presenting At GKM Healthcare Investor Conference; Live Presentation to be Webcast April 8th from New York.
Aphton to Present at Rodman & Renshaw 7th Annual Healthcare Conference.
Advanced Cell Technology's Chief Scientific Officer Michael West, Ph.D. to be Featured Guest Speaker at Rodman & Renshaw Techvest 7th Annual...
Panacos to Present at Bear Stearns Healthcare Conference.
Invitrogen to Present at Lehman Brothers Ninth Annual Global Healthcare Conference.
Advanced Cell Technology to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference.
Corgenix to Present at Rodman & Renshaw Techvest 8th Annual Healthcare Conference on November 8, 2006.
Panacos to Present at Rodman & Renshaw's 8th Annual Healthcare Conference.
CompuMed to Present at Rodman & Renshaw Techvest 8th Annual Healthcare Conference on November 8, 2006.
Advanced Cell Technology's CEO to Present at Rodman & Renshaw 4th Annual Global Healthcare Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles